Expanding Oversight of Opioid Prescribing and Payment Act of 2018
Official title: To require the Medicare Payment Advisory Commission to report on opioid payment, adverse incentives, and data under the Medicare program.
More subjectsShow fewer subjects
Have a question about what this bill does? Ask in plain English; the answer is drawn from the bill's actual text and official record, and it'll tell you when something isn't in the text rather than guess.
Received in the Senate and Read twice and referred to the Committee on Finance.
Expanding Oversight of Opioid Prescribing and Payment Act of 2018
(Sec. 2) This bill requires the Medicare Payment Advisory Commission to report to Congress on: (1) how Medicare pays for opioid and non-opioid pain management treatments in inpatient and outpatient hospital settings; (2) current incentives for prescribing opioid and non-opioid treatments under Medicare inpatient and outpatient prospective payment systems, along with recommendations to address any identified adverse incentives; and (3) how opioid use is currently tracked and monitored through Medicare and any areas for improvement.
- Engrossed in House Formatted Text PDF Formatted XML
- Introduced in House Formatted Text PDF Formatted XML
- Referred in Senate Formatted Text PDF Formatted XML
- Reported in House Formatted Text PDF Formatted XML
Cite this page
U.S. Congress. (2026). H.R. 5723: Expanding Oversight of Opioid Prescribing and Payment Act of 2018. 115th Congress. Open America. https://openamerica.io/bill/115-HR-5723/
"H.R. 5723: Expanding Oversight of Opioid Prescribing and Payment Act of 2018." 115th Congress, 2026, Open America, https://openamerica.io/bill/115-HR-5723/.
H.R. 5723, 115th Cong. (2026), https://openamerica.io/bill/115-HR-5723/.
[H.R. 5723: Expanding Oversight of Opioid Prescribing and Payment Act of 2018](https://openamerica.io/bill/115-HR-5723/)